Deerfield Management Company, L.P. (Series C) Vera Therapeutics, Inc. Put Options Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VERA
# of Institutions
199Shares Held
62.3MCall Options Held
1.51MPut Options Held
268K-
Avoro Capital Advisors LLC New York, NY6.3MShares$133 Million2.71% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.48MShares$94.7 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.43MShares$72.4 Million9.64% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$70.6 Million0.0% of portfolio
-
Vestal Point Capital, LP New York, NY3.1MShares$65.5 Million3.85% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $572M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...